Tempest Therapeutics (TPST) Short Interest Ratio & Short Volume $6.96 +0.74 (+11.90%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tempest Therapeutics Short Interest DataTempest Therapeutics (TPST) has a short interest of 125,700 shares, representing 3.95% of the float (the number of shares available for trading by the public). This marks a -92.82% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.8, indicating that it would take 1.8 days of the average trading volume of 156,912 shares to cover all short positions.Current Short Interest125,700 sharesPrevious Short Interest1,750,000 sharesChange Vs. Previous Month-92.82%Dollar Volume Sold Short$1.21 millionShort Interest Ratio1.8 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares3,519,000 sharesFloat Size3,180,000 sharesShort Percent of Float3.95%Today's Trading Volume56,458 sharesAverage Trading Volume156,912 sharesToday's Volume Vs. Average36% Short Selling Tempest Therapeutics? Sign up to receive the latest short interest report for Tempest Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTPST Short Interest Over TimeTPST Days to Cover Over TimeTPST Percentage of Float Shorted Over Time Remove Ads Tempest Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025125,700 shares $1.21 million -92.8%4.0%1.8 $9.59 3/15/20251,750,000 shares $1.47 million -17.8%4.4%1.7 $0.84 2/28/20252,130,000 shares $1.72 million +1.0%5.4%1.8 $0.81 2/15/20252,110,000 shares $1.96 million -18.9%5.3%1.7 $0.93 1/31/20252,600,000 shares $2.38 million -16.9%6.6%1.7 $0.92 1/15/20253,130,000 shares $2.79 million +20.4%7.9%1.5 $0.89 12/31/20242,600,000 shares $2.17 million -19.5%6.6%0.7 $0.83 12/15/20243,230,000 shares $2.58 million +29.7%8.2%0.9 $0.80 11/30/20242,490,000 shares $2.37 million +18.6%6.7%0.7 $0.95 11/15/20242,100,000 shares $1.87 million -20.5%5.7%0.6 $0.89 Get the Latest News and Ratings for TPST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/20242,640,000 shares $2.42 million -29.0%11.8%0.5 $0.92 10/15/20243,720,000 shares $4.35 million +100.0%17.6%0.9 $1.17 9/30/20241,860,000 shares $2.60 million -3.1%8.8%0.8 $1.40 9/15/20241,920,000 shares $2.78 million -6.3%9.1%0.8 $1.45 8/31/20242,050,000 shares $2.64 million -2.8%9.9%0.7 $1.29 8/15/20242,110,000 shares $3.27 million +4.5%10.2%0.7 $1.55 7/31/20242,020,000 shares $3.60 million +4.1%11.6%2 $1.78 7/15/20241,940,000 shares $4.31 million +3.2%11.1%2 $2.22 6/30/20241,880,000 shares $4.12 million +16.8%10.8%2 $2.19 6/15/20241,610,000 shares $4.67 million -1.8%9.2%1.2 $2.90 5/31/20241,640,000 shares $5.44 million -2.4%9.4%2 $3.32 5/15/20241,680,000 shares $5.68 million +6.3%9.6%2 $3.38 4/30/20241,580,000 shares $5.48 million +39.8%9.4%1.8 $3.47 4/15/20241,130,000 shares $3.77 million +16.5%6.7%1.2 $3.34 3/31/2024969,700 shares $3.79 million +26.5%6.1%0.9 $3.91 3/15/2024766,800 shares $2.79 million +7.0%4.2%1 $3.64 2/29/2024716,500 shares $2.66 million -17.7%4.5%0.8 $3.71 2/15/2024870,400 shares $3.46 million +14.5%5.4%0.8 $3.98 1/31/2024759,900 shares $2.88 million +37.1%5.6%0.4 $3.79 1/15/2024554,300 shares $2.34 million +19.6%4.1%0.2 $4.23 12/31/2023463,400 shares $2.04 million -44.8%3.4%0 $4.40 12/15/2023838,900 shares $3.45 million +31.4%6.2%0.1 $4.11 11/30/2023638,600 shares $2.24 million -54.1%5.8%0.1 $3.52 11/15/20231,390,000 shares $4.59 million -0.7%12.5%0.1 $3.30 10/31/20231,400,000 shares $5.74 million -36.1%18.2%0.1 $4.10 10/15/20232,190,000 shares $7.97 million +7,200.0%28.5%0.3 $3.64 9/30/202330,000 shares $9,141.00 -64.7%0.4%0.1 $0.30 9/15/202385,000 shares $41,378.00 +161.5%1.1%0.6 $0.49 8/31/202332,500 shares $17,485.00 +128.9%0.5%0.3 $0.54 8/15/202314,200 shares $9,315.20 -58.6%0.2%0.1 $0.66Why War with China Start in 128 Days (Ad)The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we believe are in immediate danger.There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K, 7/31/202334,300 shares $33,271.00 -15.9%0.6%0.4 $0.97 7/15/202340,800 shares $47,532.00 +58.1%0.7%0.2 $1.17 6/30/202325,800 shares $32,766.00 -39.3%0.5%0.1 $1.27 6/15/202342,500 shares $60,350.00 +6.5%0.7%0.2 $1.42 5/31/202339,900 shares $61,047.00 -48.8%0.8%0.2 $1.53 5/15/202377,900 shares $169,822.00 +144.2%1.5%0.3 $2.18 4/30/202331,900 shares $67,628.00 -3.3%0.8%0.1 $2.12 4/15/202333,000 shares $97,350.00 -29.9%0.8%1.1 $2.95 3/31/202347,100 shares $109,272.00 +262.3%1.1%1.8 $2.32 3/15/202313,000 shares $16,380.00 -21.2%0.3%0.8 $1.26 2/28/202316,500 shares $29,040.00 +17.9%0.4%1 $1.76 2/15/202314,000 shares $24,360.00 -21.4%0.3%0.9 $1.74 1/31/202317,800 shares $35,422.00 -41.3%0.3%1.1 $1.99 1/15/202330,300 shares $52,419.00 +31.7%0.7%1.9 $1.73 12/30/202223,000 shares $26,450.00 +33.7%0.5%1.6 $1.15 12/15/202217,200 shares $24,768.00 -12.2%0.4%1.9 $1.44 11/30/202219,600 shares $31,322.76 +22.5%0.4%1.2 $1.60 11/15/202216,000 shares $26,400.00 -20.8%0.4%0.8 $1.65 10/31/202220,200 shares $37,370.00 +3.1%0.4%0.8 $1.85 10/15/202219,600 shares $31,164.00 -9.7%0.4%0.7 $1.59 9/30/202221,700 shares $37,758.00 -10.0%0.5%0.8 $1.74 9/15/202224,100 shares $56,876.00 +28.2%0.5%0.8 $2.36 8/31/202218,800 shares $40,608.00 -68.4%0.4%0.7 $2.16 8/15/202259,400 shares $147,906.00 -39.6%1.3%1.3 $2.49 7/31/202298,400 shares $199,752.00 -20.6%2.2%1.6 $2.03 7/15/2022123,900 shares $314,706.00 -7.3%2.8%0.4 $2.54 6/30/2022133,600 shares $287,240.00 -23.6%3.0%0.4 $2.15 6/15/2022174,900 shares $372,537.00 -24.5%3.9%0.5 $2.13 5/31/2022231,700 shares $667,296.00 +23.2%12.4%0.7 $2.88 5/15/2022188,000 shares $541,440.00 -59.0%14.5%0.6 $2.88 4/30/2022458,800 shares $1.66 million +1,835.9%14.5%1.6 $3.61 4/15/202223,700 shares $80,817.00 +22.8%0.8%0.7 $3.41 3/31/202219,300 shares $65,234.00 +1.1%0.6%0.6 $3.38 3/15/202219,100 shares $44,121.00 -19.4%0.6%0.6 $2.31 2/28/202223,700 shares $77,262.00 +2.2%0.8%0.7 $3.26 2/15/202223,200 shares $80,504.00 -12.5%0.7%0.8 $3.47 1/31/202226,500 shares $105,205.00 -18.0%0.5%0.9 $3.97 1/15/202232,300 shares $132,753.00 -0.6%0.6%1.1 $4.11 12/31/202132,500 shares $171,600.00 +8.7%0.6%1.2 $5.28 12/15/202129,900 shares $210,795.00 -19.2%0.6%1.7 $7.05 11/30/202137,000 shares $366,300.00 -19.9%0.7%1.6 $9.90 11/15/202146,200 shares $509,586.00 -16.3%0.9%1.5 $11.03 10/29/202155,200 shares $646,944.00 -2.8%1.1%1.1 $11.72 10/15/202156,800 shares $833,824.00 -30.7%1.1%0.5 $14.68 9/30/202182,000 shares $1.19 million +0.7%1.7%0.2 $14.47 9/15/202181,400 shares $1.26 million +93.4%1.6%0.1 $15.44 8/31/202142,100 shares $606,661.00 -56.1%0.9%0.1 $14.41 8/13/202195,900 shares $1.28 million No ChangeN/A0.1 $13.30 6/15/20212,420,000 shares $3.48 million +22.2%15.1%1.1 $1.44 5/28/20211,980,000 shares $2.36 million +28.6%12.3%1.2 $1.19Why War with China Start in 128 Days (Ad)The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we believe are in immediate danger.There's a good chance you own at least one of these through a brokerage account, mutual fund, 401K, 5/14/20211,540,000 shares $1.48 million +31.6%N/A1.1 $0.96 4/30/20211,170,000 shares $1.33 million +3.5%N/A1 $1.14 4/15/20211,130,000 shares $1.22 million +123.1%N/A1.3 $1.08 3/31/2021506,400 shares $648,192.00 +62.5%N/A0.6 $1.28 3/15/2021311,600 shares $663,708.00 -0.5%N/A0.5 $2.13 2/26/2021313,000 shares $694,860.00 -28.3%N/A0.5 $2.22 2/12/2021436,700 shares $1.14 million -33.0%N/A0.7 $2.62 1/29/2021651,400 shares $1.21 million -7.3%N/A1.1 $1.86 1/15/2021702,700 shares $1.28 million +55.6%N/A1.4 $1.82 12/31/2020451,600 shares $961,908.00 +11.9%N/A1 $2.13 12/15/2020403,500 shares $786,825.00 -26.6%N/A1 $1.95 11/30/2020549,700 shares $1.03 million -13.5%N/A1.6 $1.88 11/15/2020635,800 shares $979,132.00 +36.2%N/A1.8 $1.54 10/30/2020466,800 shares $690,864.00 -51.2%N/A1.3 $1.48 10/15/2020955,500 shares $1.61 million +39.2%N/A2.3 $1.69 9/30/2020686,400 shares $1.12 million +25.9%N/A1.2 $1.63 9/15/2020545,100 shares $877,611.00 +38.5%N/A0.9 $1.61 8/31/2020393,500 shares $712,235.00 -22.8%N/A0.3 $1.81 8/14/2020509,700 shares $942,945.00 -39.1%N/A0.4 $1.85 7/31/2020836,500 shares $1.45 million -6.5%N/A0.6 $1.73 7/15/2020894,800 shares $1.52 million -10.5%N/A0.6 $1.70 6/30/20201,000,000 shares $1.76 million +32.4%7.5%0.6 $1.76 6/15/2020755,100 shares $1.53 million +34.6%5.7%0.5 $2.02 5/29/2020561,100 shares $1.49 million +5.9%4.2%0.5 $2.66 5/15/2020529,800 shares $863,574.00 +19.9%4.0%0.6 $1.63 4/30/2020442,000 shares $738,140.00 +43.6%3.4%0.6 $1.67 4/15/2020307,900 shares $489,561.00 +6.3%2.8%0.6 $1.59 TPST Short Interest - Frequently Asked Questions What is Tempest Therapeutics' current short interest? Short interest is the volume of Tempest Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 125,700 shares of TPST short. 3.95% of Tempest Therapeutics' shares are currently sold short. Learn More on Tempest Therapeutics' current short interest. What is a good short interest ratio for Tempest Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TPST shares currently have a short interest ratio of 2.0. Learn More on Tempest Therapeutics's short interest ratio. Which institutional investors are shorting Tempest Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tempest Therapeutics: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Tempest Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.95% of Tempest Therapeutics' floating shares are currently sold short. Is Tempest Therapeutics' short interest increasing or decreasing? Tempest Therapeutics saw a decline in short interest in March. As of March 31st, there was short interest totaling 125,700 shares, a decline of 92.8% from the previous total of 1,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tempest Therapeutics' float size? Tempest Therapeutics currently has issued a total of 3,519,000 shares. Some of Tempest Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tempest Therapeutics currently has a public float of 3,180,000 shares. How does Tempest Therapeutics' short interest compare to its competitors? 3.95% of Tempest Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tempest Therapeutics: OptiNose, Inc. (2.42%), Instil Bio, Inc. (17.02%), Coya Therapeutics, Inc. (1.89%), Oramed Pharmaceuticals Inc. (1.87%), Immunic, Inc. (2.31%), CervoMed Inc. (19.68%), Galectin Therapeutics Inc. (18.09%), Atossa Therapeutics, Inc. (6.97%), Zentalis Pharmaceuticals, Inc. (6.94%), Editas Medicine, Inc. (15.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Tempest Therapeutics stock? Short selling TPST is an investing strategy that aims to generate trading profit from Tempest Therapeutics as its price is falling. TPST shares are trading up $0.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tempest Therapeutics? A short squeeze for Tempest Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TPST, which in turn drives the price of the stock up even further. How often is Tempest Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TPST, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies OptiNose Short Interest Instil Bio Short Interest Coya Therapeutics Short Interest Oramed Pharmaceuticals Short Interest Immunic Short Interest CervoMed Short Interest Galectin Therapeutics Short Interest Atossa Therapeutics Short Interest Zentalis Pharmaceuticals Short Interest Editas Medicine Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TPST) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TPST Stock Free TPST Stock Alerts